TY - JOUR
T1 - The effects of apolipoprotein E deficiency on brain cholinergic neurons
AU - Kleifeld, Oded
AU - Diebler, Marie Francoise
AU - Chapman, Shira
AU - Oron, Lea
AU - Michaelson, Daniel M.
N1 - Funding Information:
This work was supported in part by grants to D.M.M. from the U.S.–Israel Binational ScienceFoundation (grant no. 95/16) ; from the Israel Fund for Basic Research (grant no. 670/96) ; fromthe Eichenbaum Foundation and from the Revah-Kabelli Fund ; by a grant to M.F.D. and D.M.M.from the French–Israeli Joint Arc en Ciel Project, and by a stipend to O.K. from the RubinowiczFoundation. D.M.M. is the incumbent of the Myriam Lebach Chair in Molecular Neurodegenerationat Tel Aviv University. We thank Mrs Angela Cohen for editorial assistance.
PY - 1998/11/1
Y1 - 1998/11/1
N2 - Previous studies utilizing apolipoprotein E (apoE)-deficient mice revealed distinct decreases in the levels of cholinergic synaptic markers of projecting basal forebrain cholinergic neurons and no such alterations in other brain cholinergic systems. In order to investigate the mechanisms underlying these neuron-specific cholinergic effects, primary neuronal cultures from apoE-deficient and control mice were prepared and characterized. These include basal forebrain cultures, which are enriched in projecting cholinergic neurons, and cortical cultures, which contain cholinergic interneurons. The levels of cholinergic nerve terminals in these cultures were assessed by ligand binding measurements of the levels of the vesicular acetylcholine transporter (VAChT). This revealed that basal forebrain cultures of apoE-deficient mice contain markedly lower VAChT levels (~50%) than do control cultures, but that VAChT levels of the corresponding cortical cultures of the apoE-deficient and control mice were the same. Time course studies revealed that VAChT levels of the basal forebrain cultures increased with culture age, but that the relative reduction in VAChT levels of the apoE-deficient cholinergic neurons was unaltered and was the same for freshly prepared and for 96 h old cultures. These in vitro observations are in accordance with the in vivo findings and suggest that projecting basal forebrain cholinergic neurons, but not cholinergic interneurons, are markedly dependent on apoE and that similar mechanisms mediate the in vivo and in vitro effects of apoE deficiency on cholinergic function.
AB - Previous studies utilizing apolipoprotein E (apoE)-deficient mice revealed distinct decreases in the levels of cholinergic synaptic markers of projecting basal forebrain cholinergic neurons and no such alterations in other brain cholinergic systems. In order to investigate the mechanisms underlying these neuron-specific cholinergic effects, primary neuronal cultures from apoE-deficient and control mice were prepared and characterized. These include basal forebrain cultures, which are enriched in projecting cholinergic neurons, and cortical cultures, which contain cholinergic interneurons. The levels of cholinergic nerve terminals in these cultures were assessed by ligand binding measurements of the levels of the vesicular acetylcholine transporter (VAChT). This revealed that basal forebrain cultures of apoE-deficient mice contain markedly lower VAChT levels (~50%) than do control cultures, but that VAChT levels of the corresponding cortical cultures of the apoE-deficient and control mice were the same. Time course studies revealed that VAChT levels of the basal forebrain cultures increased with culture age, but that the relative reduction in VAChT levels of the apoE-deficient cholinergic neurons was unaltered and was the same for freshly prepared and for 96 h old cultures. These in vitro observations are in accordance with the in vivo findings and suggest that projecting basal forebrain cholinergic neurons, but not cholinergic interneurons, are markedly dependent on apoE and that similar mechanisms mediate the in vivo and in vitro effects of apoE deficiency on cholinergic function.
KW - Alzheimer's disease
KW - Apolipoprotein E
KW - Cholinergic
KW - VAChT
KW - Vesamicol
UR - http://www.scopus.com/inward/record.url?scp=0032462948&partnerID=8YFLogxK
U2 - 10.1016/S0736-5748(98)00084-7
DO - 10.1016/S0736-5748(98)00084-7
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
AN - SCOPUS:0032462948
SN - 0736-5748
VL - 16
SP - 755
EP - 762
JO - International Journal of Developmental Neuroscience
JF - International Journal of Developmental Neuroscience
IS - 7-8
ER -